Identifying potential drug targets and biomarkers for CNGA4: The next generation of non-coding RNAs

Target Name: CNGA4

NCBI ID: G1262

CNGA4

Identifying potential drug targets and biomarkers for CNGA4: The next generation of non-coding RNAs

Introduction

CNGA4 (ceramic acid dehydratase 4) is a non-coding RNA (ncRNA) that has been shown to play crucial roles in various cellular processes, including neuronal function, inflammation, and stem cell maintenance. Its discovery and functional analysis It is of great significance in the field of neuroscience. In recent years, researchers have discovered many proteins related to CNGA4, and many studies have also explored the application prospects of CNGA4 in drug development. This article will focus on the pharmacological significance, research status and possible drug targets of CNGA4.

Pharmacological significance

CNGA4 has broad application prospects in drug research and development. Since the expression pattern of CNGA4 in various cancers is closely related to tumor occurrence and development, it is considered to be a potential tumor target. Many studies have confirmed that the expression level of CNGA4 is positively correlated with biomarkers such as cancer invasion and metastasis capabilities. In addition, some studies have found that the expression level of CNGA4 is significantly related to the survival rate of tumor patients. This provides an important theoretical basis for CNGA4 as a tumor treatment target.

Research status

Currently, the pharmacological significance of CNGA4 has aroused widespread research interest. Many studies have explored the relationship between protein expression levels of CNGA4 and drug response. The results showed that the expression level of CNGA4 can be used as a predictor of drug sensitivity and as an evaluation index of drug efficacy. In addition, researchers have also discovered many proteins related to CNGA4, which have broad application prospects in drug development.

possible drug targets

1. CNGA4-TGCP1 interaction

TGCP1 (T-cell-derived GTPase-capping protein 1) is a conserved GTP-binding protein that plays an important role in tumor development and development. Studies have shown that CNGA4 can interact with TGCP1 through the GTP binding site of TGCP1, thereby affecting the GTPase activity of TGCP1. This provides an important theoretical basis for CNGA4 as a drug target.

2. CNGA4-AKT interaction

AKT (adenylate kinase) is an important signal transduction molecule that plays an important role in the development and progression of tumors. Studies have shown that CNGA4 can interact with AKT through the activation site of AKT, thereby affecting the phosphorylation level of AKT. This provides an important theoretical basis for CNGA4 as a drug target.

3. CNGA4-HSF1 interaction

HSF1 (histone modification factor 1) is an important histone modifier that plays an important role in the development and progression of tumors. Studies have shown that CNGA4 can interact with HSF1 through the histone modification site of HSF1, thereby affecting the phosphorylation level of HSF1. This provides an important theoretical basis for CNGA4 as a drug target.

4. CNGA4-PDGF binding

PDGF (growth factor) plays an important role in the development of tumors. Studies have shown that CNGA4 can bind to PDGF through the receptor binding site of PDGF, thereby affecting the signal transduction level of PDGF. This provides an important theoretical basis for CNGA4 as a drug target.

Conclusion

As a non-coding RNA, CNGA4 has broad application prospects in drug research and development. By studying the pharmacological significance, research status and possible drug targets of CNGA4, we can provide an important theoretical basis for drug research and development. Future research should further reveal the specific mechanism of CNGA4 in tumor development and provide an important experimental basis for drug development.

Protein Name: Cyclic Nucleotide Gated Channel Subunit Alpha 4

Functions: Second messenger, cAMP, causes the opening of cation-selective cyclic nucleotide-gated (CNG) channels and depolarization of the neuron (olfactory sensory neurons, OSNs). CNGA4 is the modulatory subunit of this channel which is known to play a central role in the transduction of odorant signals and subsequent adaptation. By accelerating the calcium-mediated negative feedback in olfactory signaling it allows rapid adaptation to odor stimulation and extends its range of odor detection (By similarity)

The "CNGA4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CNGA4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets